Department of Surgery, Hospital Virgen de las Nieves, University of Granada, Granada, Spain.
Thromb Res. 2013 Jun;131(6):e240-6. doi: 10.1016/j.thromres.2013.03.014. Epub 2013 Apr 9.
Venous thromboembolism (VTE) is major health problem worldwide with substantial morbidity and mortality. This study aimed to assess post-operative VTE prophylaxis duration and adherence to the American College of Chest Physicians (ACCP) 2008 guidelines in patients having undergone major orthopaedic surgery (MOS).
This multinational, longitudinal, observational registry recruited consecutive patients (≥ 18 years of age) who underwent total hip replacement (THR), total knee replacement (TKR), and hip fracture surgery (HFS). There were 3 study visits: at admission to hospital, at discharge, and 4/6 weeks after surgery. Data on demographics, medical history, VTE risk factors, type and duration of mechanical and pharmacological prophylaxis, complications, and adherence to the ACCP 2008 guidelines were collected using case report forms.
Between October 2009 and July 2011, 2162 eligible patients were analyzed: THR: 646, TKR: 740, HFS: 776 (mean age [SD]: 64.5 [15.0] years; female: 61.3%; and mean hospitalization duration [SD]: 9.1 [8.2] days). VTE prophylaxis was prescribed to 96.2% of patients during hospitalization and 89.7% of patients after hospital discharge. Prophylaxis was prescribed according to the ACCP 2008 guidelines in 85.7% of patients during hospitalization and 63.4% of patients after hospital discharge. The main reasons for non-adherence to guidelines were no prescription and inadequate duration of prophylaxis. The low molecular weight heparin-enoxaparin-was the most commonly prescribed prophylaxis.
We observed a gap between real life VTE prophylaxis and the ACCP 2008 recommendations. Improved prescription of extended thromboprophylaxis is warranted to ensure adherence to international guidelines.
静脉血栓栓塞症(VTE)是全球范围内的一个重大健康问题,具有较高的发病率和死亡率。本研究旨在评估接受大型骨科手术后(MOS)患者的术后 VTE 预防持续时间和对美国胸科医师学会(ACCP)2008 指南的依从性。
这项多中心、纵向、观察性登记研究纳入了连续的患者(≥18 岁),他们接受了全髋关节置换术(THR)、全膝关节置换术(TKR)和髋部骨折手术(HFS)。有 3 次研究访视:入院时、出院时和手术后 4/6 周。使用病例报告表收集了人口统计学、病史、VTE 风险因素、机械和药物预防的类型和持续时间、并发症以及对 ACCP 2008 指南的依从性等数据。
2009 年 10 月至 2011 年 7 月期间,分析了 2162 名符合条件的患者:THR:646 例,TKR:740 例,HFS:776 例(平均年龄[标准差]:64.5[15.0]岁;女性:61.3%;平均住院时间[标准差]:9.1[8.2]天)。96.2%的患者在住院期间和 89.7%的患者在出院后开具了 VTE 预防药物。在住院期间,85.7%的患者和出院后 63.4%的患者按照 ACCP 2008 指南开具了预防药物。不遵守指南的主要原因是未开具处方和预防持续时间不足。低分子肝素依诺肝素是最常开具的预防药物。
我们观察到实际 VTE 预防与 ACCP 2008 建议之间存在差距。需要改进延长血栓预防的处方,以确保遵守国际指南。